Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic

CoronaVac is one of two Chinese vaccines already sustaining vaccination campaigns in more than 70 nations. Both should soon be much more widely available to low-income countries.
  1. Smriti Mallapaty
    View author publications

    You can also search for this author in PubMed  Google Scholar

The World Health Organization (WHO) has approved a second Chinese vaccine for emergency use. CoronaVac was found to be 51% effective at preventing COVID-19 in late-stage trials, and researchers say it will be key to curbing the pandemic.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 594, 161-162 (2021)

doi: https://doi.org/10.1038/d41586-021-01497-8

References

  1. Palacios, R. et al. Preprint at SSRN https://doi.org/10.2139/ssrn.3822780 (2021).

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links